2019
DOI: 10.1177/2050313x19838442
|View full text |Cite
|
Sign up to set email alerts
|

Combination of oral vancomycin and intra-colonic vancomycin: Successful treatment of complicated pseudomembranous colitis in a child patient

Abstract: The Clostridium difficile infection–related disease varies from mild diarrhoea to pseudomembranouscolitis. Although C. difficile infection is commonly considered to be a hospital-acquired infection, a significant number of cases are community acquired. Community-acquired C. difficile infection can exhibit itself as ileus or toxic megacolon. Severe C. difficile infection that is unresponsive to intravenous metronidazole therapy requires more aggressive medical management and even surgical intervention. We prese… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…Especially, the dextran-based microgels are of great interest in developing colon-specific drug delivery microgels, , in which the drugs can be encapsulated and protected against hydrolysis from the stomach and small intestine, but can be triggered by an enzyme, Dextranase, and delivered when they enter into the colon region . Moreover, these microgels can be used for local therapies of the colonic diseases, such as Crohn’s disease, ulcerative colitis, pseudomembranous colitis, inflammatory bowel disease, and colorectal cancer . This will not only reduce the necessary drug dose but also lower the harmful adverse effects .…”
Section: Introductionmentioning
confidence: 99%
“…Especially, the dextran-based microgels are of great interest in developing colon-specific drug delivery microgels, , in which the drugs can be encapsulated and protected against hydrolysis from the stomach and small intestine, but can be triggered by an enzyme, Dextranase, and delivered when they enter into the colon region . Moreover, these microgels can be used for local therapies of the colonic diseases, such as Crohn’s disease, ulcerative colitis, pseudomembranous colitis, inflammatory bowel disease, and colorectal cancer . This will not only reduce the necessary drug dose but also lower the harmful adverse effects .…”
Section: Introductionmentioning
confidence: 99%